Crystal-induced arthritis: An overview

American Journal of Medicine

Volumn 100, Issue 2 A, 1996, Pages

  Schumacher Jr , H Ralph ^a,b  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b HOSPITAL OF THE UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM PYROPHOSPHATE; URATE; HYDROXYAPATITE; NONSTEROID ANTIINFLAMMATORY AGENT; URIC ACID;

ANTIINFLAMMATORY ACTIVITY; ARTHROPATHY; CLINICAL FEATURE; CONFERENCE PAPER; CRYSTAL STRUCTURE; DEGENERATIVE DISEASE; GOUT; HUMAN; HYPERPHOSPHATEMIA; PERIARTHRITIS; PHOSPHATE BLOOD LEVEL; PRIORITY JOURNAL; PSEUDOGOUT; RECURRENT DISEASE; SCREENING TEST; TENDINITIS; TREATMENT PLANNING; ARTHRITIS; CHEMISTRY; CHONDROCALCINOSIS; CRYSTALLIZATION; REVIEW; SYNOVIAL FLUID;

ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ARTHRITIS; ARTHRITIS, GOUTY; CALCIUM PYROPHOSPHATE; CHONDROCALCINOSIS; CRYSTALLIZATION; DURAPATITE; HUMANS; PERIARTHRITIS; SYNOVIAL FLUID; URIC ACID;

EID: 0030602461     PISSN: 00029343     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (22)

1. Reginato A, Paul H, Schumacher HR. Crystal-induced arthritis. Arch Phys Med Rehabil. 1982;63:401-408.
2. Schumacher HR Jr, Reginato AJ. Calcium pyrophosphate dihydrate crystals. In: Schumacher HR Jr, Reginato AJ, eds. Atlas of Synovial Fluid and Crystal Identification. Philadelphia: Lea & Febiger, 1991:121-132.
3. Eisenberg JM, Schumacher HR, Davidson PK, Kaufmann L. Usefulness of synovial fluid analysis in the evaluation of joint effusions. Use of threshold analysis and likelihood ratios to assess a diagnostic test. Arch Intern Med. 1984;144:715-719.
4. Baker DG, Schumacher HR Jr. Acute monoarthritis. N Engl J Med. 1993;329:1013-1020.
5. Schumacher HR Jr, Moreno Alvarez JM, Clues to common crystal-induced arthropathies. IM. 1993;14:35-47.
6. McCarty DJ. A historical note: Leeuwenhoek's description of crystals from a gouty tophus. Arthritis Rheum. 1970;13:414-418.
7. Levinson DJ, Becker MA. Clinical gout and the pathogenesis of hyperuricemia. In: McCarty DJ, Koopman WJ, eds. Arthritis and Allied Conditions, 12th ed. Philadelphia: Lea & Febiger, 1993:1773-1805.
8. Yü TF, Gutman AB. Principles of current management of primary gout. Am J Med Sci. 1967;254:893-907.
9. McCarty DJ, Hollander JL. Identification of urate crystals in gouty synovial fluid. Ann Intern Med. 1961;54:452-460.
10. Dorwart BB, Hansell JR, Schumacher HR Jr. Effects of cold and heat on urate crystal-induced synovitis in dog. Arthritis Rheum. 1974;17:563-571.
11. Wallace SL, Singer JZ. Therapy in gout. Rheum Dis Clin North Am. 1988;14:441.
12. Reginato AJ, Schumacher HR Jr. Crystal-associated arthropathies. Clin Geriatr Med. 1988;4:295-322.
13. Halz-Leblanc BAE, Reynolds WJ, MacFadden DK. Allopurinol hypersensitivity in a patient with chronic tophaceous gout: success of intravenous densensitization after failure of oral densensitization. Arth Rheum. 1991;34:1329-1331.
14. Zitnan D, Sitaj S. Chondrocalcinosis articularis section. I. Clinical and radiological study. Ann Rheum Dis. 1963;22:142-152.
15. McCarty DJ Jr, Kohn N, Faires JS. The significance of calcium phosphate crystals in the synovial fluid of arthritic patients: the "pseudogout syndrome." I. Clinical aspects. Ann Intern Med. 1962;56:711-737.
16. McCarty DJ. Calcium pyrophosphate dihydrate crystal deposition disease -1975. Arthritis Rheum. 1976;19:275-285.
17. Ferrari AJL, Van Linthoudt D, Schumacher HR. Evaluation of synovial fluids for crystals. Rheum Rev. 1992;1:193-203.
18. Alvarellos A, Spilberg I. Colchicine prophylaxis in pseudogout. J Rheumatol. 1986;13:804-805.
19. Dieppe P, Crocker P, Huskisson EC, Willoughby DA. Apatite deposition disease: new arthropathy. Lancet 1976;i:266-269.
20. Schumacher HR, Somlyo AP, Tse RL, Maurer K. Arthritis associated with apatite crystal. Ann Intern Med. 1977;87:411-416.
21. Codman EA. The Shoulder. Boston: Thomas Todd, 1932.
22. Murphy BB, Schumacher HR. How does patient education affect gout? Clin Rheumatol Prac. 1984;March/April:77-80.